Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kliniken Essen-Mitte (KEM) is a leading academic teaching hospital group based in Essen, Germany, affiliated with the University of Duisburg-Essen. The organization operates as a top-tier provider of specialized medical care across three main sites, including the Evang. Huyssens-Stiftung and the Knappschafts-Krankenhaus. KEM is internationally recognized for its excellence in oncology, particularly in gynecological and breast cancers, and is a global pioneer in the field of Integrative Medicine. As a non-profit healthcare entity, it combines state-of-the-art clinical practice with robust participation in international clinical trials, serving as a major hub for Phase 2 and Phase 3 oncology research. The hospital group maintains over 1,000 beds and employs a multidisciplinary team dedicated to complex disease management and patient-centered care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kliniken Essen-Mitte.